Radiopharmaceutical Imaging And
Dosimetry, Llc
Dba Radiopharmaceutical Imaging &
Dosimetry Llc
CAGE Code: 7L1Q8
NCAGE Code: 7L1Q8
Status: Active
Type: Commercial Supplier
Summary
Radiopharmaceutical Imaging And, Dosimetry, Llc, Dba Radiopharmaceutical Imaging &, Dosimetry Llc is an Active Commercial Supplier with the Cage Code 7L1Q8.
Address
1800 Gough St
Baltimore MD 21231-2607
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Graybar Electric Company, Inc. Gvb Enterprises Reville Services Vicks Consulting Llc Safety-Kleen Corp Best Western Hotel Bobker Bearing Amilburn Co Yankee Engineering Co Inc Transunion Llc Century Autoline Metal Lubricants Merico Sales Inc Inphomation Communications Inc Morris James B Enterprise Banah Construction Crook H E Co Inc Maryland Shipbuilding And Drydock Co Alexanders Moving & Storage Eastern Broad Spectrum Optics Llc Whitehead Metals Inc
Frequently Asked Questions (FAQ) for CAGE 7L1Q8
- What is CAGE Code 7L1Q8?
- 7L1Q8 is the unique identifier used by NATO Organizations to reference the physical entity known as Radiopharmaceutical Imaging And Dosimetry, Llc Dba Radiopharmaceutical Imaging & Dosimetry Llc located at 1800 Gough St, Baltimore MD 21231-2607, United States.
- Who is CAGE Code 7L1Q8?
- 7L1Q8 refers to Radiopharmaceutical Imaging And Dosimetry, Llc Dba Radiopharmaceutical Imaging & Dosimetry Llc located at 1800 Gough St, Baltimore MD 21231-2607, United States.
- Where is CAGE Code 7L1Q8 Located?
- CAGE Code 7L1Q8 is located in Baltimore, MD, USA.
Contracting History for CAGE 7L1Q8 Most Recent 25 Records
- 75N91019C00040
- Eo14042 - Topic 368: Treatment Optimization By Combined A-Emitter (Arpt)/Radiotherapy (Xrt) Dosimetry For Prostate Cancer Patients
- 16 Nov 2021
- Eo14042 - Topic 368: Treatment Optimization By Combined A-Emitter (Arpt)/Radiotherapy (Xrt) Dosimetry For Prostate Cancer Patients
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $1,999,796.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00047
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- 13 Dec 2021
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,275.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00047
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- 15 Mar 2022
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,275.00
- Department Of Health And Human Services (Hhs)
- 75N91019C00047
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- 12 May 2022
- Sbir Phase I Topic 392: Targeted Radionuclide Therapy Of Metastatic Liver Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $299,275.00
- Department Of Health And Human Services (Hhs)